Nasdaq nstg.

SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced preliminary total product and service revenue of approximately $31 million for the first quarter.

Nasdaq nstg. Things To Know About Nasdaq nstg.

Nov 10, 2021 6:00am EST. SEATTLE -- (BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today ...10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced that it has won an injunction in its patent litigation against NanoString Technologies, Inc. (Nasdaq ...Cathie Wood-led Ark Investment Management nearly halved the Apple Inc (NASDAQ:AAPL) stake in the ARK Fintech Innovation ETF (NYSE:ARKF) on Thursday.. ARKF shed 298,505 Apple shares, worth about ...Maybe you’ve never invested before. Maybe you have no clue what the difference is between NASDAQ and the New York Stock Exchange. Regardless, the name Charles Schwab probably rings a bell.To find the current corn price per bushel, there are a number of websites and places to look for predictions about the commodities market. Corn prices are listed on sites like NASDAQ and AgWeb if you want a quick answer.

Dec 4, 2023 · NanoString Technologies last posted its earnings results on November 6th, 2023. The biotechnology company reported ($0.78) earnings per share for the quarter, missing analysts' consensus estimates of ($0.53) by $0.25. The company had revenue of $48.09 million for the quarter, compared to analyst estimates of $46.05 million.

Sep 19, 2023 · NanoString Technologies (NSTG) fell 10% on a report that a German court announced a preliminary injunction against it over a patent dispute with 10X Genomics (TXG). 10x Genomics rose 0.5%

While NanoString Technologies, Inc. ( NASDAQ:NSTG) might not be the most widely known stock at the moment, it saw a double-digit share price rise of over 10% in the past couple of months on the ...NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to participate in a panel discussion, “AI-Driven Disruptions To Genomics & Computational Drug Discovery”, from the 43 rd Annual Cowen Health Care …NanoString Technologies (NSTG) came out with a quarterly loss of $0.88 per share versus the Zacks Consensus Estimate of a loss of $0.72. This compares to loss of $0.86 per share a year ago.SEATTLE, March 08, 2023--NanoString Technologies, Inc. (Nasdaq: NSTG), a leading provider of life science tools for discovery and translational research, today announced, as required by Nasdaq ...

Balance Sheet. Stock analysis for NanoString Technologies Inc (NSTG:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and …

Find the latest news headlines from NanoString Technologies, Inc. Common Stock (NSTG) at Nasdaq.com.

SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported preliminary financial and operational highlights for the second quarter ended June 30, 2023. “We are excited to report that our teams delivered strong …NanoString Technologies, Inc. (NASDAQ:NSTG) Q3 2023 Earnings Call Transcript November 6, 2023 NanoString Technologies, Inc. misses on earnings expectations.A high-level overview of NanoString Technologies, Inc. (NSTG) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported financial results for the first quarter ended March 31, 2021. First Quarter Financial Highlights. Product and service revenue of $31.4 million, 28% year-over-year growthNanoString Technologies (NSTG) fell 10% on a report that a German court announced a preliminary injunction against it over a patent dispute with 10X Genomics (TXG). 10x Genomics rose 0.5%NASDAQ NSTG opened at $0.50 on Thursday. The company has a market cap of $24.26 million, a P/E ratio of -0.14 and a beta of 1.67. NanoString Technologies has a 1 year low of $0.47 and a 1 year high of $13.20. The company has a current ratio of 2.73, a quick ratio of 2.02 and a debt-to-equity ratio of 16.67. The company has a fifty day simple ...Nov 3, 2023 · Nanostring Technologies Inc (NASDAQ:NSTG)’s traded shares stood at 1.12 million during the last session, with the company’s beta value hitting 1.66. At the close of trading, the stock’s price was $1.41, to imply an increase of 4.44% or $0.06 in intraday trading. The NSTG share’s 52-week high ...

Jun 4, 2022 · While NanoString Technologies, Inc. ( NASDAQ:NSTG) might not be the most widely known stock at the moment, it saw a double-digit share price rise of over 10% in the past couple of months on the ... 9h. JP Morgan has downgraded NanoString ( NASDAQ: NSTG) to neutral due to limited near-term visibility amid ongoing patent litigation. The investment bank noted that NanoString is embroiled in ...Nov 27, 2023 · According to the issued ratings of 6 analysts in the last year, the consensus rating for NanoString Technologies stock is Hold based on the current 4 hold ratings and 2 buy ratings for NSTG. The average twelve-month price prediction for NanoString Technologies is $7.63 with a high price target of $10.00 and a low price target of $2.50. NanoString Technologies, Inc. (NASDAQ:NSTG) Q3 2023 Earnings Call Transcript November 6, 2023 NanoString Technologies, Inc. misses on earnings expectations. Reported EPS is $-0.78 EPS ...The new research reports from Fundamental Markets, available for free download at the links above, examine NanoString Technologies, Inc. (NASDAQ:NSTG), Oaktree Capital Group, LLC (NYSE:OAK ...The new research reports from Fundamental Markets, available for free download at the links above, examine Cisco Systems, Inc. (NASDAQ:CSCO), NanoString Technologies, Inc. (NASDAQ:NSTG), Galapagos ...

NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced the publication of a study in the ...SEATTLE-- (BUSINESS WIRE)--NanoString Technologies, Inc. (Nasdaq: NSTG), a leading provider of life science tools for discovery and translational research, …

Jun 4, 2022 · While NanoString Technologies, Inc. ( NASDAQ:NSTG) might not be the most widely known stock at the moment, it saw a double-digit share price rise of over 10% in the past couple of months on the ... NanoString Technologies last posted its earnings results on November 6th, 2023. The biotechnology company reported ($0.78) earnings per share for the quarter, missing analysts' consensus estimates of ($0.53) by $0.25. The company had revenue of $48.09 million for the quarter, compared to analyst estimates of $46.05 million.See the latest NanoString Technologies Inc stock price (NSTG:XNAS), related news, valuation, dividends and more to help you make your investing decisions.SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported financial results for the fourth quarter and fiscal year ended December 31, 2022. “We are thrilled with the momentum that’s building in the spatial biology market.Find the latest Earnings Report Date for NanoString Technologies, Inc. Common Stock (NSTG) at Nasdaq.com. Average. $4.86. Current Price. $0.55. Options. Overview. Research & Ratings. Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume ...

Find the latest Institutional Holdings data for NanoString Technologies, Inc. Common Stock (NSTG) at Nasdaq.com.

Nov 30, 2023 · In 2022, NSTG's revenue was $127.26 million, a decrease of -12.28% compared to the previous year's $145.09 million. Losses were -$159.54 million, 38.4% more than in 2021. Financial Statements.

To find the current corn price per bushel, there are a number of websites and places to look for predictions about the commodities market. Corn prices are listed on sites like NASDAQ and AgWeb if you want a quick answer.NanoString press release ( NASDAQ: NSTG ): Q2 GAAP EPS of -$0.92 misses by $0.21. Revenue of $44.2M (+37.2% Y/Y) misses by $0.1M. Management reiterated its full year guidance, which remains as ...NanoString Technologies Inc (NASDAQ:NSTG) NanoString Technologies Inc. 1.28. Delayed Data. As of Nov 17. -0.05 / -3.76%. Today’s Change.The latest price target for . NanoString Technologies (NASDAQ: NSTG) was reported by Baird on November 21, 2023.The analyst firm set a price target for $0.75 expecting NSTG to rise to within 12 ...Insiders who bought US$6.21m worth of NanoString Technologies, Inc. ( NASDAQ:NSTG) stock in the last year have seen some of their losses recouped as the stock gained 30% last week. However, the ...NanoString Technologies, Inc. Common Stock (NSTG) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.In 2022, NSTG's revenue was $127.26 million, a decrease of -12.28% compared to the previous year's $145.09 million. Losses were -$159.54 million, 38.4% more than in 2021. Financial Statements.SEATTLE and CAMBRIDGE, UK, April 01, 2019 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic ...NSTG's stock price has decreased by -92.21% in the past year and price targets may not have had time to catch up. Stock Price Forecast According to 5 stock analysts, the average 12-month stock price forecast for NSTG stock stock is $2.83, which predicts an increase of 410.46%.SEATTLE, January 08, 2023--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported preliminary financial and ...Nanostring Technologies Inc (NASDAQ:NSTG) Sarepta Therapeutics Inc (NASDAQ:SRPT) Roche Holding Ag (OTC:RHHBY) Pluristem Therapeutics Inc (NASDAQ:PSTI) KE Holdings (NYSE:BEKE) Baidu Inc (NASDAQ ...

SEATTLE, March 26, 2019 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today ...NanoString Technologies (NSTG) fell 10% on a report that a German court announced a preliminary injunction against it over a patent dispute with 10X Genomics (TXG). 10x Genomics rose 0.5%NanoString Technologies, Inc. (NASDAQ:NSTG) Q3 2023 Earnings Call Transcript. Published on November 7, 2023 at 10:52 am by Insider Monkey Transcripts in News, Transcripts. So if you really – if ...Instagram:https://instagram. eli lilly stock dividendstocks to buy right nowbest arkansas bankss and p 500 ytd 2023 Nanostring Technologies (NASDAQ: NSTG) is owned by 102.08% institutional shareholders, 56.27% Nanostring Technologies insiders, and 0.00% retail investors. Clarus Lifesciences Ii LP is the largest individual Nanostring Technologies shareholder, owning 6.07M shares representing 12.62% of the company.2022 has been brutal for this stock, which is down by 76% year-to-date. The share losses have come alongside real world decline, as exhibited in the latest quarterly statement - for 2Q22. Revenue ... reputable gold sellerskrystal biotech inc. SEATTLE, Feb. 29, 2016 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today ... forex us brokers (NASDAQ: NSTG) Nanostring Technologies's 52-week high was $13.20, and its 52-week low was $0.47. It is currently -96.03% from its 52-week high and 11.25% from its 52-week …We will take a look at NanoString Technologies Inc (NASDAQ:NSTG), Chimera Investment Corporation (NYSE:CIM), Renewable Energy Group Inc (NASDAQ:REGI), Sogou Inc. (NYSE:SOGO), Live Oak Bancshares ...Published on November 7, 2023 at 10:52 am by Insider Monkey Transcripts in News, Transcripts. I don’t think I can really be too quantitative about that. I think overall, it’s fair to say ...